For example, in leukaemia, the ability to initiate new tumor growth resides in a rare phenotypically distinct subset of tumor cells [3] that are defined by the expression of CD34+CD38- surface antigens and have been termed leukemic stem cells. This evidence concerns the gene CD34 and neoplasm.